In The News: School of Integrated Health Sciences
Finding the motivation to commute to a gym — not to mention working out when you get there — is a struggle. It’s time to take advantage of that little thing we do each time we run errands, park our cars, or take the stairs: walking.
UB-311 could offer multiple competitive advantages over licensed passive immunotherapies, including less frequent dosing, a more convenient mode of administration, improved accessibility and cost-effectiveness, and potentially lower rates of ARIA-E
With its depiction of the first atomic bomb explosion, the new film, "Oppenheimer," highlights the massive destructive power of these early nuclear weapons.
Radioactive particles from nuclear explosions are found in every corner of the world. Many people are worried about the bad effects of nuclear bombs.
Aqua jogging, or deep water running, is popular among injured runners since it’s a non-weight-bearing exercise that’s very similar to running. If athletes can’t go on their normal runs because of injuries, they can maintain their aerobic performance for several weeks with aqua jogging.
A daily serving of strawberries can improve cognitive function and heart health, a new study finds.
Research presented at Berry Health Benefits Symposium adds to growing body of evidence and highlights strawberry’s ‘food as medicine’ potential.
The drugs clear sticky plaques from the brain. But they are not for everyone, experts caution
Autopsy is currently the only way to definitively diagnose chronic traumatic encephalopathy (CTE), a degenerative brain disease often seen in athletes who've suffered repeated blows to the head.
Autopsy is currently the only way to definitively diagnose chronic traumatic encephalopathy (CTE), a degenerative brain disease often seen in athletes who've suffered repeated blows to the head.
The latest report on clinical trials in the Alzheimer’s drug development pipeline points to the growing potential of anti-amyloid monoclonal antibodies for treating the brain-robbing condition. Anti-inflammatory agents comprise the single largest therapeutic category with 25 drugs, but astoundingly no two are aimed at the same target, according to lead author Jeffrey Cummings, M.D., research professor in the school of integrated health sciences at the ҳ| 鶹ýӳ, and director of its Chambers-Grundy Center for Transformative Neuroscience.
Newly approved anti-amyloid therapies have spurred hope for patients and caregivers affected by Alzheimer's disease, but access to these drugs could be stymied by a lack of convenient and available beta-amyloid testing options.